Lovingly Park

Lovingly Park has extensive experience in clinical research specializing in neuroscience and neurology. Currently serving as Director of Clinical Research-Neuroscience at Eli Lilly and Company since October 2025, Lovingly previously held roles as Senior Director and Director of Clinical Development at Alector, where strategic leadership was provided in the design and execution of clinical trials. Additionally, Lovingly has contributed as a Neuroscience Steering Committee Member at the Foundation for the National Institutes of Health and has held positions at Supernus Pharmaceuticals and Parexel, focusing on early-phase studies and regulatory compliance. Educational qualifications include a Ph.D. in Clinical Psychology from Alliant International University, along with several post-doctoral fellowships and clinical training in neuropsychology, culminating in a diverse background that bridges clinical practice and research innovation in neuropsychological assessment and treatment.